GSK Investigational Site

Rhyl LL18 5UJ

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Ovarian Neoplasms, Platinum Sensitive Ovarian Cancer

Studies at this site

• A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma — Completed
• A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer — Completed